Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Induction Phase	STARTED	BNX Sublingual Tablets Induction	155
Induction Phase	STARTED	Buprenorphine Induction	155
Induction Phase	COMPLETED	BNX Sublingual Tablets Induction	132
Induction Phase	COMPLETED	Buprenorphine Induction	147
Induction Phase	NOT COMPLETED	BNX Sublingual Tablets Induction	23
Induction Phase	NOT COMPLETED	Buprenorphine Induction	8
Stabilization/Maintenance	STARTED	BNX Sublingual Tablets Induction	132
Stabilization/Maintenance	STARTED	Buprenorphine Induction	147
Stabilization/Maintenance	COMPLETED	BNX Sublingual Tablets Induction	92
Stabilization/Maintenance	COMPLETED	Buprenorphine Induction	107
Stabilization/Maintenance	NOT COMPLETED	BNX Sublingual Tablets Induction	40
Stabilization/Maintenance	NOT COMPLETED	Buprenorphine Induction	40

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01848054/flow